Ammar Sabilarrohman

FDA Places Clinical Hold on REGENXBIO’s RGX-121 Gene Therapy for Hunter Syndrome Amidst Unforeseen MRI Findings fda-places-clinical-hold-on-regenxbios-rgx-121-gene-therapy-for-hunter-syndrome-amidst-unforeseen-mri-findings

FDA Places Clinical Hold on REGENXBIO’s RGX-121 Gene Therapy for Hunter Syndrome Amidst Unforeseen MRI Findings

Ammar Sabilarrohman August 26, 2026

A significant setback has been announced in the development of RGX-121, an investigational gene therapy from REGENXBIO...

A New Era of Health Sovereignty: African Nations Spearhead Landmark WHO Investment Round a-new-era-of-health-sovereignty-african-nations-spearhead-landmark-who-investment-round

A New Era of Health Sovereignty: African Nations Spearhead Landmark WHO Investment Round

Ammar Sabilarrohman August 25, 2026

In a historic display of regional solidarity and forward-thinking diplomacy, 14 African nations have collectively pledged over...

Bridging the Genetic Divide: Inside the Broad Institute’s New Mission to Translate Discovery into Cures bridging-the-genetic-divide-inside-the-broad-institutes-new-mission-to-translate-discovery-into-cures

Bridging the Genetic Divide: Inside the Broad Institute’s New Mission to Translate Discovery into Cures

Ammar Sabilarrohman August 25, 2026

For the past two decades, the scientific community has operated under a powerful, albeit frustrating, promise: that...

Global Health at a Crossroads: G20 Nations Rally Behind WHO’s Landmark Investment Round global-health-at-a-crossroads-g20-nations-rally-behind-whos-landmark-investment-round-2

Global Health at a Crossroads: G20 Nations Rally Behind WHO’s Landmark Investment Round

Ammar Sabilarrohman August 25, 2026

Introduction: A New Paradigm for Global Health Security In a significant diplomatic and public health breakthrough, health...

Strengthening the Global Health Architecture: A Deep Dive into the Belgium-WHO Strategic Dialogue strengthening-the-global-health-architecture-a-deep-dive-into-the-belgium-who-strategic-dialogue-1

Strengthening the Global Health Architecture: A Deep Dive into the Belgium-WHO Strategic Dialogue

Ammar Sabilarrohman August 24, 2026

In an era defined by rapid epidemiological shifts, climate-induced health crises, and a fragile global geopolitical landscape,...

Navigating the Storm: Empowering Children When a Parent Faces Cancer navigating-the-storm-empowering-children-when-a-parent-faces-cancer

Navigating the Storm: Empowering Children When a Parent Faces Cancer

Ammar Sabilarrohman August 23, 2026

A cancer diagnosis is a seismic event that ripples through every aspect of a family’s life. For...

Revolutionizing Hospital Biosecurity: Perimeter and Culturewell Launch Advanced Multi-Layered Infection Surveillance Programme revolutionizing-hospital-biosecurity-perimeter-and-culturewell-launch-advanced-multi-layered-infection-surveillance-programme

Revolutionizing Hospital Biosecurity: Perimeter and Culturewell Launch Advanced Multi-Layered Infection Surveillance Programme

Ammar Sabilarrohman August 22, 2026

In a significant leap forward for public health and hospital management, biosecurity firm Perimeter and outbreak detection...

Ending the Wait-and-See Era: AbbVie’s Maviret Redefines Hepatitis C Treatment Standards ending-the-wait-and-see-era-abbvies-maviret-redefines-hepatitis-c-treatment-standards

Ending the Wait-and-See Era: AbbVie’s Maviret Redefines Hepatitis C Treatment Standards

Ammar Sabilarrohman August 21, 2026

In a landmark regulatory shift, the European Commission has granted approval for AbbVie’s Maviret (glecaprevir/pibrentasvir)—marketed as Mavyret...

The Complex Intersection of GLP-1 Medications and Plastic Surgery: A New Frontier in Patient Safety the-complex-intersection-of-glp-1-medications-and-plastic-surgery-a-new-frontier-in-patient-safety

The Complex Intersection of GLP-1 Medications and Plastic Surgery: A New Frontier in Patient Safety

Ammar Sabilarrohman August 21, 2026

As the popularity of glucagon-like peptide-1 (GLP-1) receptor agonists—such as semaglutide and liraglutide—reaches an all-time high, the...

A New Era for Preventive Medicine: Breast Cancer Canada Applauds Federal Advisory Committee Launch a-new-era-for-preventive-medicine-breast-cancer-canada-applauds-federal-advisory-committee-launch

A New Era for Preventive Medicine: Breast Cancer Canada Applauds Federal Advisory Committee Launch

Ammar Sabilarrohman August 20, 2026

OTTAWA – In a significant move aimed at modernizing Canada’s healthcare framework, the federal government has officially...

FDA Places Clinical Hold on REGENXBIO’s RGX-121 Gene Therapy for Hunter Syndrome Amidst Unforeseen MRI Findings

A New Era of Health Sovereignty: African Nations Spearhead Landmark WHO Investment Round

Bridging the Genetic Divide: Inside the Broad Institute’s New Mission to Translate Discovery into Cures

Global Health at a Crossroads: G20 Nations Rally Behind WHO’s Landmark Investment Round

Strengthening the Global Health Architecture: A Deep Dive into the Belgium-WHO Strategic Dialogue

Navigating the Storm: Empowering Children When a Parent Faces Cancer

Revolutionizing Hospital Biosecurity: Perimeter and Culturewell Launch Advanced Multi-Layered Infection Surveillance Programme

Ending the Wait-and-See Era: AbbVie’s Maviret Redefines Hepatitis C Treatment Standards

The Complex Intersection of GLP-1 Medications and Plastic Surgery: A New Frontier in Patient Safety

A New Era for Preventive Medicine: Breast Cancer Canada Applauds Federal Advisory Committee Launch

You may have missed

The Great Insurance Debate: Dissecting the Role of Health Insurers in America’s Fiscal Crisis

Beyond the Cream: How a Father’s Quest for Relief Sparked a Skincare Revolution

Salk Scientists Unveil Estrogen-Related Receptors as Key to Unlocking Energy Metabolism and Combating Muscle Fatigue

The Architecture of Hope: Mapping the Centuries-Long Evolution of Breast Cancer Treatment